Company · CIK 0001636282 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Spyre Therapeutics, Inc. · SYRE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 3, 9:34 pm EDT | Heidy King-JonesSee Remarks | 28,399 | $87.35 | $2,480,529 | 2,845 | −90.9% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 9:34 pm EDT | Heidy King-JonesSee Remarks | 28,399 | $14.50 | $411,786 | 3,245 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 9:33 pm EDT | Scott L BurrowsChief Financial Officer | 25,732 | $88.75 | $2,283,821 | 79,762 | −24.4% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 9:33 pm EDT | Scott L BurrowsChief Financial Officer | 7,500 | $14.50 | $108,750 | 105,494 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 9:33 pm EDT | Cameron TurtleChief Executive Officer, Director | 15,000 | $87.29 | $1,309,410 | 552,540 | −2.64% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 MForm 4 → | Sep 3, 9:34 pm EDT | Heidy King-JonesSee Remarks | 28,399 | — | — | 511,411 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 9:33 pm EDT | Scott L BurrowsChief Financial Officer | 7,500 | — | — | 337,357 | — | 10b5-1 |